AAAAAA

   
Results: 1-8 |
Results: 8
LONG-TERM EFFICACY AND TOLERABILITY OF MULTIPLE IV DOSES OF THE FULLYHUMAN ANTI-TNF-ANTIBODY D2E7 IN PATIENTS WITH RHEUMATOID-ARTHRITIS
Authors: RAU R SANDER O DENBROEDER A VANRIEL PLCM VANDERPUTTE L KRUGER K SCHATTENKIRCHER M FENNER H LASSMANN A KUPPER H KEMPENI J
Citation: R. Rau et al., LONG-TERM EFFICACY AND TOLERABILITY OF MULTIPLE IV DOSES OF THE FULLYHUMAN ANTI-TNF-ANTIBODY D2E7 IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 41(9), 1998, pp. 137-137
A SINGLE-DOSE PLACEBO-CONTROLLED PHASE-1 STUDY OF THE FULLY HUMAN ANTI-TNF ANTIBODY D2E7 IN PATIENTS WITH RHEUMATOID-ARTHRITIS
Authors: VANDEPUTTE LBA VANRIEL PLCM DENBROEDER A SANDER O RAU R BINDER C KRUGER K SCHATTENKIRCHER M FENNER H SALFELD J BANKMANN Y KUPPER H KEMPENI J
Citation: Lba. Vandeputte et al., A SINGLE-DOSE PLACEBO-CONTROLLED PHASE-1 STUDY OF THE FULLY HUMAN ANTI-TNF ANTIBODY D2E7 IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 41(9), 1998, pp. 148-148
EFFICACY AND TOLERABILITY OF WEEKLY SUBCUTANEOUS INJECTIONS OF THE FULLY HUMAN ANTI-TNF-ANTIBODY D2E7 IN PATIENTS WITH RHEUMATOID-ARTHRITIS- RESULTS OF A PHASE-I STUDY
Authors: SCHATTENKIRCHNER M KRUGER K SANDER O RAU R KROOT EJ VANRIEL PLCM VANDEPUTTE L FENNER H KEMPENI J KUPPER H
Citation: M. Schattenkirchner et al., EFFICACY AND TOLERABILITY OF WEEKLY SUBCUTANEOUS INJECTIONS OF THE FULLY HUMAN ANTI-TNF-ANTIBODY D2E7 IN PATIENTS WITH RHEUMATOID-ARTHRITIS- RESULTS OF A PHASE-I STUDY, Arthritis and rheumatism, 41(9), 1998, pp. 149-149
ASSESSMENT OF THE SAFETY AND EFFICACY OF THE MONOCLONAL ANTITUMOR NECROSIS FACTOR ANTIBODY-FRAGMENT, MAK 195F, IN PATIENTS WITH SEPSIS AND SEPTIC SHOCK - A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING STUDY
Authors: REINHART K WIEGANDLOHNERT C GRIMMINGER F KAUL M WITHINGTON S TREACHER D ECKART J WILLATTS S BOUZA C KRAUSCH D STOCKENHUBER F EISELSTEIN J DAUM L KEMPENI J
Citation: K. Reinhart et al., ASSESSMENT OF THE SAFETY AND EFFICACY OF THE MONOCLONAL ANTITUMOR NECROSIS FACTOR ANTIBODY-FRAGMENT, MAK 195F, IN PATIENTS WITH SEPSIS AND SEPTIC SHOCK - A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING STUDY, Critical care medicine, 24(5), 1996, pp. 733-742
KINETICS OF SOLUBLE TNF-RECEPTORS AND SOLUBLE ADHESION MOLECULES ICAM-1, E-SELECTIN AND VCAM-1 UNDER SYSTEMIC RHTNF-ALPHA THERAPY
Authors: BOEHME MWJ WALDHERR R KIST A RIEDL S WALTERKIRST R KEMPENI J RAETH U
Citation: Mwj. Boehme et al., KINETICS OF SOLUBLE TNF-RECEPTORS AND SOLUBLE ADHESION MOLECULES ICAM-1, E-SELECTIN AND VCAM-1 UNDER SYSTEMIC RHTNF-ALPHA THERAPY, European journal of clinical investigation, 26(5), 1996, pp. 404-410
MODULATION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION BY TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) RELEASE IN THE COURSE OF PRETRANSPLANT CONDITIONING - ROLE OF CONDITIONING REGIMENS AND PROPHYLACTIC APPLICATION OF A MONOCLONAL-ANTIBODY NEUTRALIZING HUMAN TNF-ALPHA (MAK 195F)
Authors: HOLLER E KOLB HJ MITTERMULLER J KAUL M LEDDEROSE G DUELL T SEEBER B SCHLEUNING M HINTERMEIERKNABE R ERTL B KEMPENI J WILMANNS W
Citation: E. Holler et al., MODULATION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION BY TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) RELEASE IN THE COURSE OF PRETRANSPLANT CONDITIONING - ROLE OF CONDITIONING REGIMENS AND PROPHYLACTIC APPLICATION OF A MONOCLONAL-ANTIBODY NEUTRALIZING HUMAN TNF-ALPHA (MAK 195F), Blood, 86(3), 1995, pp. 890-899
REPEATED ADMINISTRATION OF A F(AB')2 FRAGMENT OF AN ANTITUMOR NECROSIS FACTOR-ALPHA MONOCLONAL-ANTIBODY IN PATIENTS WITH SEVERE SEPSIS - EFFECTS ON THE CARDIOVASCULAR-SYSTEM AND CYTOKINE LEVELS
Authors: BOEKSTEGERS P WEIDENHOFER S ZELL R PILZ G HOLLER E ERTEL W KAPSNER T REDL H SCHLAG G KAUL M KEMPENI J STENZEL R WERDAN K
Citation: P. Boekstegers et al., REPEATED ADMINISTRATION OF A F(AB')2 FRAGMENT OF AN ANTITUMOR NECROSIS FACTOR-ALPHA MONOCLONAL-ANTIBODY IN PATIENTS WITH SEVERE SEPSIS - EFFECTS ON THE CARDIOVASCULAR-SYSTEM AND CYTOKINE LEVELS, Shock, 1(4), 1994, pp. 237-245
CHANGES IN SKELETAL-MUSCLE PO2 AFTER ADMINISTRATION OF ANTI-TNF-ALPHA-ANTIBODY IN PATIENTS WITH SEVERE SEPSIS - COMPARISON TO INTERLEUKIN-6SERUM LEVELS, APACHE-II, AND ELEBUTE SCORES
Authors: BOEKSTEGERS P WEIDENHOFER S ZELL R HOLLER E KAPSNER T REDL H SCHLAG G KAUL M KEMPENI J WERDAN K
Citation: P. Boekstegers et al., CHANGES IN SKELETAL-MUSCLE PO2 AFTER ADMINISTRATION OF ANTI-TNF-ALPHA-ANTIBODY IN PATIENTS WITH SEVERE SEPSIS - COMPARISON TO INTERLEUKIN-6SERUM LEVELS, APACHE-II, AND ELEBUTE SCORES, Shock, 1(4), 1994, pp. 246-253
Risultati: 1-8 |